3T Biosciences develops transformative T-cell receptor (TCR) therapeutics aimed at treating solid tumors and immune-mediated diseases in diverse patient populations. The company addresses the limitations of current immunotherapies by enhancing the specificity and efficacy of T-cell responses against cancer cells.

A-Alpha Bio utilizes its AlphaSeq and AlphaBind platforms to generate high-resolution protein-protein interaction data at scale, enabling the discovery and engineering of effective protein therapeutics. The company addresses the challenge of limited high-quality interaction data, which hampers the understanding and treatment of diseases such as cancer and neurological disorders.

Arzeda utilizes Intelligent Protein Design Technology™, combining physics-based protein design and AI, to create novel proteins and enzymes that enhance product performance across various industries. This approach addresses the need for sustainable and efficient alternatives in food production, personal care, and materials, reducing environmental impact while improving functionality.

The startup develops a data conversion and storage platform that encodes digital information into deoxyribonucleic acid (DNA) format, providing a long-term archival solution. This technology enables customers to economically store vast amounts of data in DNA molecules, addressing the limitations of traditional digital storage methods.

This food technology company develops and produces plant-based egg products using cellular agriculture. Their offerings provide a sustainable protein source with low saturated fat and cholesterol, serving as an alternative to traditional animal-derived eggs.

Intrinsic offers an AI‑driven software platform that simplifies robot automation by providing a unified development environment, Flowstate, where users can create digital twins, add perception and motion‑planning skills, and generate collision‑free trajectories without deep robotics expertise. The platform’s ready‑to‑use capabilities and containerized IntrinsicOS enable rapid design, simulation, and deployment of production‑grade automation solutions across cloud and on‑premise systems.

Lygos creates bio‑inspired, biodegradable, water‑soluble specialty chemicals that replace traditional petrochemical additives in agronomy, home‑care, personal‑care, and water‑treatment formulations. Their flagship polymer, Soltellus™, improves cleaning performance, formulation stability, and cost efficiency while offering a commercial‑scale, integrated supply chain and full technical documentation for rapid product development.

Numat designs and scales metal‑organic frameworks (MOFs) that capture, decontaminate, and destroy hazardous chemicals, enabling advanced filtration and separation solutions for defense, chemical manufacturing, and clean‑energy applications. Their modular platform delivers high‑capacity, reusable materials that can be integrated into personal protective equipment and industrial processes, reducing health risks and environmental impact.

Numerion Labs offers an AI-driven platform that maps and screens an ultra‑large chemical space to identify drug‑like small molecules for pharmaceutical and biotech R&D. The system combines the COSMOS foundation model for activity prediction, the APEX enumerator that evaluates billions of virtual compounds in seconds, and EXPO optimization algorithms that fine‑tune models without extensive training data, accelerating hit identification and lead optimization.

Pivot Bio is an agricultural technology company that utilizes microbial solutions to convert atmospheric nitrogen into a form that is readily accessible to plants. This process enhances soil fertility and reduces the reliance on synthetic fertilizers, addressing nutrient deficiencies in crops.

Synthego provides chemically synthesized guide RNAs, GMP‑grade Cas nucleases, and related molecular biology reagents for genome‑editing research and therapeutic development. Their custom manufacturing and regulatory‑compliant services enable academic labs and biotech companies to obtain consistent, scalable components for discovery and IND‑ready applications.

Truvian Sciences is developing an automated benchtop blood testing analyzer that delivers lab-accurate results for a suite of routine tests from a single drop of blood, eliminating the need for off-site lab processing. This technology provides healthcare providers with immediate insights during patient appointments, enhancing decision-making and patient care.

Verge Genomics utilizes a proprietary all-in-human, AI-powered drug discovery platform that integrates machine learning with a large multi-omics database derived from human tissue. The company focuses on developing effective treatments for neurodegenerative diseases, including amyotrophic lateral sclerosis, by rapidly translating insights from human biology into drug candidates.